RARE 2022 will follow on from the success of its predecessors, continuing to address the challenges of Rare Diseases. During the conference, LynxCare will be presenting our hTTR use case.
Rare Diseases 2022 was held to provide comprehensive and up-to-date information on the diagnosis, treatment, and management of rare diseases. Experts discussed the latest advances in clinical care and research. Break-out sessions focused on topics such as: genetics, clinical trials, patient advocacy, and medical economics. The overall goal of the congress was to understand the complexities of rare diseases and to work together to ensure the best care and quality of life for patients.